Company Filing History:
Years Active: 2023-2025
Title: Haridha Shivram: Innovator in CRISPR Technology
Introduction: Haridha Shivram, a talented inventor based in Berkeley, CA, is making significant contributions to the field of genetic engineering through his innovative work in CRISPR technology. With two patents to his name, Shivram's research is at the forefront of advancements that promise to enhance gene editing capabilities.
Latest Patents: Haridha Shivram's latest patents include groundbreaking discoveries in polypeptides that modulate the activity of CRISPR/Cas9 systems. The first patent, titled "Modulators of CAS9 Polypeptides and Methods of Use Thereof," outlines novel AcrIIA7 polypeptides and related nucleic acids designed to inhibit the activity of Cas9 polypeptides. This disclosure also highlights various kits that incorporate these innovative components. The second patent, "Modulators of Cas9 Polypeptide Activity and Methods of Use Thereof," provides additional polypeptides aimed at inhibiting the activity of CRISPR/Cas effector polypeptides, along with the corresponding nucleic acids and systems. Together, these patents represent significant steps toward enhancing the precision and efficacy of CRISPR technology.
Career Highlights: Haridha Shivram is associated with the University of California, where he continually pushes the boundaries of genetic research. His work not only contributes to academic knowledge but also holds promise for practical applications in medicine and biotechnology.
Collaborations: Throughout his career, Shivram has collaborated with renowned researchers, including Jennifer A. Doudna, a pioneer in the field of CRISPR gene editing, and Kyle E. Watters. These collaborations have allowed him to leverage diverse expertise, driving forward the development of innovative solutions in genetic modification.
Conclusion: As an inventor, Haridha Shivram exemplifies the spirit of innovation in the rapidly evolving field of genetic engineering. His work at the University of California, particularly in developing modulators of CRISPR technology, demonstrates the potential for transformative impacts on medicine and beyond. With his continued dedication to research and collaboration, he is poised to make further groundbreaking advancements in the field.